Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Drug-Coated Balloons in the Management of Coronary Artery Disease.
Korjian S, McCarthy KJ, Larnard EA, Cutlip DE, McEntegart MB, Kirtane AJ, Yeh RW.
Circ Cardiovasc Interv. 2024 May;17(5):e013302. doi: 10.1161/CIRCINTERVENTIONS.123.013302. Epub 2024 May 21.
Angioplasty with drug-coated balloon catheters: the coming tide?
Byrne RA, Durand R.
EuroIntervention. 2024 Jul 1;20(13):e786-e788. doi: 10.4244/EIJ-E-24-00035.
Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial.
Gao X, Tian N, Kan J, Li P, Wang M, Sheiban I, Figini F, Deng J, Chen X, Santoso T, Shin ES, Munawar M, Wen S, Wang Z, Nie S, Li Y, Xu T, Wang B, Ye F, Zhang J, Shou X, Chen SL.
J Am Coll Cardiol. 2025 Jan 7;85(1):1-15. doi: 10.1016/j.jacc.2024.08.067. Epub 2024 Oct 28.
Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients.
Megaly M, Ali A, Abraham B, Khalil C, Zordok M, Shaker M, Tawadros M, Hennawy BS, Elbadawi A, Omer M, Saad M.
Cardiovasc Revasc Med. 2020 Jan;21(1):78-85. doi: 10.1016/j.carrev.2019.03.001. Epub 2019 Mar 13.
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives.
Lunardi M, Zivelonghi C, van den Brink FS, Ghione M, Vinco G, Benfari G, Scarsini R, Ribichini F, Agostoni P.
Cardiovasc Revasc Med. 2018 Mar;19(2):215-220. doi: 10.1016/j.carrev.2017.09.002. Epub 2017 Sep 10.
Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
Gao C, He X, Liu Y, Liu J, Jiang Z, Zhu B, Qin X, Xia Y, Zhang T, Wang P, Zhang R, Onuma Y, Xia J, Wang D, Serruys P, Tao L.
BMC Cardiovasc Disord. 2024 Jun 24;24(1):319. doi: 10.1186/s12872-024-03974-0.
Dexamethasone-eluting vascular stents.
Hämäläinen M, Nieminen R, Uurto I, Salenius JP, Kellomäki M, Mikkonen J, Kotsar A, Isotalo T, Teuvo Tammela LJ, Talja M, Moilanen E.
Basic Clin Pharmacol Toxicol. 2013 May;112(5):296-301. doi: 10.1111/bcpt.12056. Epub 2013 Mar 9.
Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease.
Yerasi C, Case BC, Forrestal BJ, Kolm P, Dan K, Torguson R, Weintraub WS, Garcia-Garcia HM, Waksman R.
Cardiovasc Revasc Med. 2020 Apr;21(4):549-555. doi: 10.1016/j.carrev.2020.01.012. Epub 2020 Jan 16.
Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter.
Sanchez-Perez I, Abellan-Huerta J, Jurado-Roman A, Lopez-Lluva MT, Pinilla-Echeverri N, Perez-Diaz P, Piqueras-Flores J, Lozano-Ruiz-Poveda F.
Angiology. 2021 Apr;72(4):364-370. doi: 10.1177/0003319720979246. Epub 2020 Dec 17.
